Mark E. Jones

机构：Mental Health Commission, Basilea Pharmaceutica (Switzerland), National Health Service Wales

发表论文 116 篇 · 总被引 4380 次 · h-index 33

代表论文

• Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002) (2004 · Annals of Clinical Microbiology and Antimicrobials · 被引 271)
• Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy (2003 · International Journal of Antimicrobial Agents · 被引 229)
• Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002) (2003 · Clinical Infectious Diseases · 被引 167)
• Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4 (2017 · Transplant Infectious Disease · 被引 134)
• Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia (2023 · New England Journal of Medicine · 被引 114)
• Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001 (2003 · Antimicrobial Agents and Chemotherapy · 被引 75)